Ryman Healthcare Past Earnings Performance
Past criteria checks 1/6
Ryman Healthcare has been growing earnings at an average annual rate of 6.3%, while the Healthcare industry saw earnings growing at 4.6% annually. Revenues have been growing at an average rate of 10.1% per year. Ryman Healthcare's return on equity is 5.2%, and it has net margins of 40.6%.
Key information
6.3%
Earnings growth rate
5.2%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 10.1% |
| Return on equity | 5.2% |
| Net Margin | 40.6% |
| Next Earnings Update | 26 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Ryman Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 617 | 251 | 0 | 0 |
| 30 Jun 23 | 593 | 254 | 0 | 0 |
| 31 Mar 23 | 569 | 258 | 0 | 0 |
| 31 Dec 22 | 552 | 432 | 0 | 0 |
| 30 Sep 22 | 535 | 605 | 0 | 0 |
| 30 Jun 22 | 522 | 649 | 0 | 0 |
| 31 Mar 22 | 509 | 693 | 0 | 0 |
| 31 Dec 21 | 495 | 593 | 0 | 0 |
| 30 Sep 21 | 481 | 492 | 0 | 0 |
| 30 Jun 21 | 469 | 458 | 0 | 0 |
| 31 Mar 21 | 456 | 423 | 0 | 0 |
| 31 Dec 20 | 447 | 356 | 0 | 0 |
| 30 Sep 20 | 438 | 289 | 0 | 0 |
| 30 Jun 20 | 431 | 277 | 0 | 0 |
| 31 Mar 20 | 423 | 265 | 0 | 0 |
| 31 Dec 19 | 413 | 305 | 1 | 0 |
| 30 Sep 19 | 402 | 345 | 2 | 0 |
| 30 Jun 19 | 392 | 335 | 2 | 0 |
| 31 Mar 19 | 382 | 326 | 2 | 0 |
| 31 Dec 18 | 373 | 341 | 2 | 0 |
| 30 Sep 18 | 364 | 355 | 2 | 0 |
| 30 Jun 18 | 353 | 372 | 2 | 0 |
| 31 Mar 18 | 342 | 388 | 2 | 0 |
| 31 Dec 17 | 329 | 380 | 1 | 0 |
| 30 Sep 17 | 315 | 372 | 0 | 0 |
| 30 Jun 17 | 302 | 365 | 0 | 0 |
| 31 Mar 17 | 289 | 357 | 0 | 0 |
| 31 Dec 16 | 281 | 358 | 1 | 0 |
| 30 Sep 16 | 273 | 360 | 1 | 0 |
| 30 Jun 16 | 266 | 333 | 1 | 0 |
| 31 Mar 16 | 260 | 305 | 1 | 0 |
| 31 Dec 15 | 252 | 286 | 1 | 0 |
| 30 Sep 15 | 244 | 267 | 1 | 0 |
| 30 Jun 15 | 235 | 254 | 1 | 0 |
| 31 Mar 15 | 226 | 242 | 1 | 0 |
| 31 Dec 14 | 219 | 233 | 1 | 0 |
| 30 Sep 14 | 212 | 224 | 1 | 0 |
| 30 Jun 14 | 207 | 210 | 1 | 0 |
| 31 Mar 14 | 203 | 195 | 1 | 0 |
| 31 Dec 13 | 197 | 171 | 1 | 0 |
| 30 Sep 13 | 192 | 146 | 1 | 0 |
| 30 Jun 13 | 186 | 142 | 1 | 0 |
Quality Earnings: RHCG.F has a large one-off gain of NZ$331.1M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: RHCG.F's current net profit margins (40.6%) are lower than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RHCG.F's earnings have grown by 6.3% per year over the past 5 years.
Accelerating Growth: RHCG.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: RHCG.F had negative earnings growth (-58.6%) over the past year, making it difficult to compare to the Healthcare industry average (12.5%).
Return on Equity
High ROE: RHCG.F's Return on Equity (5.2%) is considered low.